Howard Lipshitz is a Professor in the Department of Molecular Genetics at the University of Toronto. He received B.Sc. (1976) and B.Sc. (Hons.) cum laude (1977) degrees from the University of Natal, Durban, South Africa, and his M.Phil. (1980) and Ph.D. (1983) degrees in Biology from Yale University. He then carried out postdoctoral work in the Biochemistry Department at Stanford University (1983-1986). He was Assistant (1986–1992) and then Associate (1992–1995) Professor of Biology at the California Institute of Technology, Pasadena, California before moving to Toronto in 1995 as a Professor at the University of Toronto and Senior Scientist at the Research Institute of the Hospital for Sick Children. He served as Associate Director of the Hospital for Sick Children Research Institute (1997-2001); Head of what is now its Program in Developmental & Stem Cell Biology (2001–2005); and Chair of the Department of Molecular Genetics at the University of Toronto (2005–2016). From 2007 to 2010 he also served as Associate Director of the Donnelly Centre for Cellular and Biomolecular Research at the University. During his terms as department chair he spearheaded international partnerships with a focus on China: the Shanghai Institute of Biochemistry and Cell Biology (2007), Peking University (2010), Tsinghua University (2010), the University of Hong Kong (2011) and Zhejiang University (2013an ). These partnerships included an undergraduate summer research program; jointly supervised Ph.D. programs with the University of Hong Kong (2011) and Zhejiang University (2015); and the establishment of the University of Toronto–Zhejiang University Joint Centre for Genetics Research and Education (2015). Awards and honours include: the Damant Science Prize from the University of Natal (1975); South African National Scholarship (1978–1980); Helen Hay Whitney Foundation Postdoctoral Fellowship (1983-1986); Searle Foundation Scholar (1988–1991); Canada Research Chair in Developmental Biology (2001–2008); the Elliot Osserman Award of the Israel Cancer Research Fund (New York) for his distinguished service in support of cancer research (2008); appointment as an Honorary Professor of Biochemistry at the University of Hong Kong (2012–2019); as an Adjunct Professor (2015–2017) and then as Qiushi Chair Professor (2017–2020) in the Zhejiang University School of Medicine; and as a Gordon and Betty Moore Distinguished Scholar in Biology and Biological Engineering at the California Institute of Technology (2017). He was elected a Fellow of the American Association for the Advancement of Science in 1990. Dr. Lipshitz is an internationally recognized leader in the field of post-transcriptional regulation of gene expression. He has authored over 100 research papers, review articles and book chapters; edited and/or written four books; served as chair or a member of the organizing committee of multiple international conferences and workshops; served on the board of directors of scientific societies; serves on the advisory board of funding agencies and on the editorial boards of scientific journals; and served on peer review committees in the USA and Canada. His research program is funded by the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada.